Origin Life Sciences Aims For $15 Million U.S. IPO (Pending:OLSI)

0
8


SDI Productions/E+ by way of Getty Images

A Quick Take On Origin Life Sciences, Inc.

Origin Life Sciences, Inc. (OLSI) has filed to lift $15 million in an IPO of its widespread stock, in keeping with an S-1 registration statement.

The agency is

Global Diabetic Foot Ulcer Treatment Market

Global Diabetic Foot Ulcer Treatment Market (Seeking Alpha)

Statement Of Operations

Statement Of Operations (Seeking Alpha)



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here